Related Experiment Video
Updated: May 4, 2026

07:08
Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
Published on: March 6, 2018
8.1K
Ochratoxin A: developmental and reproductive toxicity-an overview
Frantisek Malir1, Vladimir Ostry, Annie Pfohl-Leszkowicz
1Department of Biology, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic.
Summary
Ochratoxin A (OTA), a mycotoxin, poses risks to reproductive health and can cause birth defects in animals. Minimizing exposure is crucial, especially for pregnant women, due to its teratogenic and reproductive toxicity.
Area of Science:
- Toxicology
- Reproductive Biology
- Environmental Health
Background:
- Ochratoxin A (OTA) is a widespread mycotoxin with known toxic effects in animals, including nephrotoxicity, hepatotoxicity, and carcinogenicity.
- Environmental toxins are increasingly suspected of impacting human reproductive health.
- OTA has demonstrated teratogenic effects in various animal models, causing reduced birth weight and craniofacial abnormalities.
Purpose of the Study:
- To review the known toxicological profile of Ochratoxin A (OTA).
- To highlight OTA's potential as a teratogen and reproductive toxicant.
- To emphasize the need for minimizing human exposure, particularly in pregnant women.
Main Methods:
- Literature review of existing toxicological and reproductive studies on Ochratoxin A.
- Analysis of animal model data regarding teratogenicity and reproductive effects.
- Synthesis of information on OTA's mechanisms of toxicity and potential human health impacts.
Main Results:
- Ochratoxin A (OTA) is a potent teratogen in multiple animal species, leading to fetal malformations and increased embryo lethality.
- OTA acts as an endocrine disruptor and reproductive toxicant, negatively impacting sperm quality and testicular function in animals.
- The precise mechanisms of OTA transfer across the human placenta and its teratogenic effects in humans remain largely unknown.
Conclusions:
- Ochratoxin A (OTA) poses significant risks to reproductive health and fetal development, supported by extensive animal data.
- OTA's teratogenic and reproductive toxicity warrants caution and efforts to minimize human exposure, especially for pregnant women.
- Further research is needed to elucidate OTA's specific mechanisms of action in humans and its full impact on reproductive health.
Related Concept Videos
Drug Toxicity: Overview
295
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
295
Toxic Reactions: Overview
4.2K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
4.2K
Teratogenicity
4.2K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Toxicity Testing in Animals
204
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
204
Toxicokinetics: Overview
314
Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
314
Types of Toxins
3.7K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.7K

